1996
DOI: 10.1016/s0735-1097(96)00239-2
|View full text |Cite
|
Sign up to set email alerts
|

Increased Risk of Non-Q Wave Myocardial Infarction After Directional Atherectomy Is Platelet Dependent: Evidence From the EPIC Trial

Abstract: The EPIC trial confirmed the increased risk of non-Q wave myocardial infarction with directional atherectomy use compared with PTCA. A bolus and 12-h infusion of the glycoprotein IIb/IIIa receptor inhibitor c7E3 abolished this excess risk. Directional atherectomy-related non-Q wave myocardial infarction appears to be platelet aggregation dependent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

1997
1997
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(20 citation statements)
references
References 27 publications
1
19
0
Order By: Relevance
“…These observations confirm the results of two previous studies, and show that the use of directed coronary atherectomy bears an increased risk of postprocedural non-Q-wave myocardial infarction after coronary interventions [36] and that rotablation in comparison to PTCA is a risk predictor of post-procedural Q wave as well as non-Q wave myocardial infarction [37] . For plain PTCA without adjunctive/alternative interventional techniques, in patients with heart failure NYHA class c3, the high risk groups are defined as follows: (1) male patients with heart failure class 3 and concomitant subacute myocardial infarction, (2) male patients with acute myocardial infarction and no pretreatment with aspirin or ACE inhibitors, but a high load of contrast medium within the procedure or, (3) female patients with an aPTT >35 s and complex stenosis morphology and/or high age >75 years.…”
Section: Discussionsupporting
confidence: 90%
“…These observations confirm the results of two previous studies, and show that the use of directed coronary atherectomy bears an increased risk of postprocedural non-Q-wave myocardial infarction after coronary interventions [36] and that rotablation in comparison to PTCA is a risk predictor of post-procedural Q wave as well as non-Q wave myocardial infarction [37] . For plain PTCA without adjunctive/alternative interventional techniques, in patients with heart failure NYHA class c3, the high risk groups are defined as follows: (1) male patients with heart failure class 3 and concomitant subacute myocardial infarction, (2) male patients with acute myocardial infarction and no pretreatment with aspirin or ACE inhibitors, but a high load of contrast medium within the procedure or, (3) female patients with an aPTT >35 s and complex stenosis morphology and/or high age >75 years.…”
Section: Discussionsupporting
confidence: 90%
“…2,7,8,21,22 The dominant role of platelets in this phenomenon is supported by evidence that a marked decrease in CK-MB elevation can be achieved with administration of potent antiplatelet agents such as glycoprotein IIb/IIIa inhibitors. 15,17,21,23 The present study suggests that lesion-specific factors may also be important for determination of CK-MB elevation. We found a strong relationship between baseline lesion characteristics (as assessed by preintervention IVUS) and subsequent CK-MB elevation.…”
Section: Discussionmentioning
confidence: 95%
“…7,8,21 Although the first 3 causes may be clinically apparent, the latter may be entirely asymptomatic and occur even during or after angiographically uneventful procedures. 2,7,8,21,22 The dominant role of platelets in this phenomenon is supported by evidence that a marked decrease in CK-MB elevation can be achieved with administration of potent antiplatelet agents such as glycoprotein IIb/IIIa inhibitors. 15,17,21,23 The present study suggests that lesion-specific factors may also be important for determination of CK-MB elevation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Percutaneous intervention for inoperable patients with LMT stenoses may be reasonable for those individuals with intractable symptoms. All groups of patients might be expected to have improved outcomes with adjunctive use of abciximab or related drugs, which have been demonstrated to decrease the risk of infarction with directional atherectomy 17 and emergency stenting 18 and are under study in the setting of elective stenting.…”
Section: Discussionmentioning
confidence: 99%